Merck CEO Robert Davis presentation at the Goldman Healthcare CEOs conference last week. The biggest takeaway is that strengthening keytruda js a key priority. And that good takeover targets still are negotiating hard despite the market conditions
https://event.webcasts.com/starthere.jsp?ei=1590161&tp_key=4727c9fb98&tp_special=8
Merck CEO Robert Davis presentation at the Goldman Healthcare...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $435.7M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 30.5¢ | 29.5¢ | $399.6K | 1.329M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 13902 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 29836 | 2 |
View Market Depth
| Last trade - 16.10pm 08/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |